Bath & Body Works earnings up next amid turnaround test

Bath & Body Works (BBWI) will report Q3 earnings on November 19, 2026. Analysts expect EPS of $0.12 on revenue of $1.55B, down 66% and 3% YoY, respectively. The company's 'Consumer First Formula' strategy is under scrutiny. Analysts have a Hold rating and a mean price target of $24.93. Investors will watch for sales stabilization and Q4 guidance.

Original reporting
Published Nov 18, 2026, 2:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BBWI
Neutral
high confidence
Mentioned
$BBWI
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BBWINeutralMed
01

Why it matters

The key decision point is the upcoming Q3 print and, more importantly, Q4 guidance for the holiday season, which the article frames as crucial to reversing sales declines into 2027.

02

Market read

This is a pre-earnings setup with explicit consensus expectations and a clear checklist for what investors will judge in the turnaround.

03

What to watch

The article emphasizes EPS and sales direction, but traders may also focus on margin drivers, inventory and promotional intensity, and whether the Amazon launch and off-mall store mix translate into measurable demand.

Relevance 6/10Novelty 6/10Timing: pre-market Nov. 19, 2026 earnings release

Background

Bath & Body Works is executing its “Consumer First Formula” turnaround, including earlier-than-planned Amazon launch, new product categories, and shifting store footprint toward off-mall locations.

Company-level read

Ticker impact

$BBWINeutralHigh confidence
Context

Bath & Body Works is scheduled to report Q3 earnings Nov. 19, with analysts forecasting EPS $0.12 and revenue $1.55B to test its turnaround plan.

Expected impact

Shares may react sharply to any guidance that confirms or contradicts the expected sequential profitability decline and full-year sales decline range.

Evidence & confidence

The article centers on the company’s upcoming earnings release and explicitly frames investor focus on Q4 holiday guidance and progress versus the guided full-year sales decline.

Market effects

Signals whether discretionary retail fragrance and specialty retail demand is stabilizing, which can influence read-across sentiment for similar retailers.

Primarily US retail sentiment, with limited direct regional spillover beyond consumer discretionary.

Low global spillover; turnaround narrative is company-specific though it can affect broader consumer discretionary risk appetite.

Counterpoint

Even if Q3 profitability declines as expected, the stock could hold up if management provides credible Q4 holiday demand signals and improves visibility into 2027.

Key entities

  • Bath & Body Works Inc.

    Fragrance and personal care retailer reporting Q3 earnings before the market opens on Nov. 19, 2026.

Related articles

$BBYMed

Sportsman's Warehouse (NASDAQ:SPWH): Strongest Q2 Results from the Specialty Retail Group

Best Buy (BBY) reported Q2 revenue of $9.78B, up 3.6% YoY, beating estimates. Its stock rose 3.7% post-earnings. Dick's (DKS) reported $5.59B revenue, up 53.2% YoY, missing estimates. Its stock fell 24.7%. Sally Beauty (SBH) reported flat revenue of $935.5M, meeting expectations. Bath & Body Works (BBWI) reported $1.51B revenue, down 2.3% YoY, beating estimates. Its stock rose 4.8%.

$BBWIMed

How Investors May Respond To Bath & Body Works (BBWI) Stronger EPS Guidance Amid Softer Sales And Buybacks

Bath & Body Works (BBWI) reported Q2 2026 net income of $118M on $1.51B sales, completed a $382.93M share buyback, and updated guidance for a 4% to 2.5% decline in full-year sales but higher EPS. The company launched the Reserve Collection, focusing on product innovation. Analysts debate the stock's value, with projections ranging from $7.2B to $7.6B revenue by 2029.

$BBWIMedAI 8/10

Bath & Body Works, Inc. Q2 2027 Earnings Call Summary

Bath & Body Works reported Q2 2027 sales beat due to digital growth and expanded distribution. The company is shifting focus to enduring franchises and exiting the Home Care category. Digital sales improved, and management reinvested $35M in marketing. Guidance was narrowed, assuming macro pressures persist. Q2 results included an $80M tariff refund benefit. Management discussed sustainability of digital growth, store traffic strategies, and partnerships with Amazon and Ulta.

$BBWIMedAI 8/10

Bath & Body Works Q2 Earnings Call Highlights

Bath & Body Works reported Q2 sales of $1.1 billion, down 5.4% YoY, with direct-channel sales up 3% and international revenue up 24.9%. The company's digital business grew, and new product launches exceeded expectations. Bath & Body Works plans to exit its home-care category and expand distribution with Amazon and Ulta. It narrowed its full-year sales outlook to a decline of 2.5% to 4% and raised adjusted EPS guidance to $2.60 to $2.80.